"Trump hosted the company's chief executive, Pascal Soriot, in the Oval Office on Friday to publicly cement the deal, which he described as another historic achievement in our quest to lower drug prices for all Americans. Americans can expect discounts, and as I said, it could be, in many cases, way over a hundred percent, Trump said. As in previous press appearances, he pledged US consumers would see impossible discounts on popular medications."
"AstraZeneca is the second major pharmaceutical after Pfizer to strike such a bargain. Last month, Pfizer announced a voluntary agreement to price its products at parity with other key developed markets. Like AstraZeneca, it also agreed to participate in an online, direct-to-consumer marketplace the Trump administration plans to launch, called TrumpRx. But in a news release on its website, Pfizer made clear that the agreement would help it dodge the high tariffs that Trump threatened against overseas"
President Donald Trump secured a direct-to-consumer agreement with AstraZeneca to offer lower-cost prescription drugs to Americans. He hosted AstraZeneca chief executive Pascal Soriot in the Oval Office and described the arrangement as a historic achievement to lower drug prices. He credited a threatened 100-percent tariff with making the deal possible and promised steep discounts, citing inhalers discounted by 654 percent and claims some medicines could see 1,000 percent reductions. The deal follows a similar agreement with Pfizer and commits AstraZeneca to participate in a planned TrumpRx online marketplace. Pfizer said its deal also helps it avoid threatened tariffs.
Read at www.aljazeera.com
Unable to calculate read time
Collection
[
|
...
]